Amberpharm sp. z o.o.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-15
Share capital
5,000.00 PLN
Activity description

Amberpharm is a specialist in dietary supplements and cosmetics designed for sensitive and allergy-prone skin. The company manufactures a wide range of products, including vitamins, probiotics, and specialized cosmetics for various skin types, while also offering comprehensive contract manufacturing services that cover all stages from product development to market entry.

Registered address
ul. Szafarnia 11/F8, 80-755 Gdańsk, Poland
Email
Phone

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 432 days for 2019).

  • 2025not filed
  • 202421/04/2025
  • 202324/04/2024
  • 202225/04/2024
  • 202108/06/2022
  • 202021/12/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Manufacture of food products429 / 762
Top 56%
Sector · Manufacturing6,930 / 11,933
Top 58%
Voivodeship · Pomorskie13,829 / 32,715
Top 42%
Country · Poland208,929 / 496,593
Top 42%

Results vs industry

Revenue
This companyUSD 300.04kMedianUSD 266.29kAverageUSD 5.23m
Net profit
This companyUSD -59.93kMedianUSD 2.04kAverageUSD 362.44k
Operating costs
This companyUSD 350.27kMedianUSD 273.60kAverageUSD 4.62m
Assets
This companyUSD 147.00kMedianUSD 215.71kAverageUSD 3.99m

Authorized Representatives

Ewa Brożek-Cantillana age 50 – Attorney-in-fact (sole)
Sergio Esteban Cantillana-Valencia age 54 – President of the Management Board

Manner of representation

President of the Management Board independently, or two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy

Ownership

OwnerSharesShare valueStake
100$1,350.62100%

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2020-02-14.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Akuna Polska sp. z o.o.
Pharma Dot sp. z o.o.
Equalan Pharma Polska sp. z o.o.
KE Pharma Spółka z Ograniczoną Odpowiedzialością sp. z o.o.
Medso sp. z o.o.
Pharmacreator Produkcja sp. z o.o.
Medcalm sp. z o.o.
DDB sp. z o.o.
Fuelup Factory sp. z o.o.
ADS Plus sp. z o.o.

Change history

DateEvent
2024-01-29PKD change
2020-02-19Address change
2019-09-18Address change
2019-03-15Entered in the register

FAQ

Last updated: 2026-10-07